Iktos SA, headquartered in France, is a pioneering company in the field of artificial intelligence for drug discovery. Founded in 2016, Iktos has rapidly established itself as a leader in the pharmaceutical industry, focusing on innovative solutions that enhance the efficiency of drug design processes. The company’s core offerings include advanced AI-driven platforms that streamline the identification and optimisation of novel compounds, setting them apart in a competitive market. With a commitment to transforming the drug development landscape, Iktos has achieved significant milestones, including collaborations with major pharmaceutical firms and recognition for its cutting-edge technology. As a key player in the biotech sector, Iktos continues to push the boundaries of computational chemistry, making substantial contributions to the future of medicine.
How does Iktos SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Iktos SA's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Iktos SA, headquartered in France, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As a result, Iktos SA's climate commitments and strategies remain unspecified, indicating a potential area for development in their sustainability practices. Without emissions data or reduction initiatives, it is challenging to assess their environmental impact or commitment to climate action within the industry context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Iktos SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

